ArticleAntibody therapeutics2024

A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variants.

Marisa L Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.